1. Home
  2. XERS
  3. XERS News

Latest Xeris Biopharma Holdings Inc. (XERS) News on October 23, 2024

Several Insiders Invested In Xeris Biopharma Holdings Flagging Positive News
XERS

Simply Wall St.

14 days ago

Several Insiders Invested In Xeris Biopharma Holdings Flagging Positive News

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
XERS

Business Wire

19 days ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Zevra Therapeutics (ZVRA) Moves 9.1% Higher: Will This Strength Last?
XERS

Zacks

a month ago

Zevra Therapeutics (ZVRA) Moves 9.1% Higher: Will This Strength Last?

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) most popular amongst individual investors who own 53% of the shares, institutions hold 43%
XERS

Simply Wall St.

a month ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) most popular amongst individual investors who own 53% of the shares, institutions hold 43%

Xeris to Participate in Upcoming Investor Conferences
XERS

Business Wire

2 months ago

Xeris to Participate in Upcoming Investor Conferences

Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates
XERS

Zacks

2 months ago

Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates

XERS

Associated Press Finance

2 months ago

Xeris Biopharma: Q2 Earnings Snapshot

Xeris Biopharma Reports Second Quarter 2024 Financial Results
XERS

Business Wire

2 months ago

Xeris Biopharma Reports Second Quarter 2024 Financial Results

Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline
XERS

Zacks

3 months ago

Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline

Will Xeris Biopharma (XERS) Report Negative Earnings Next Week? What You Should Know
XERS

Zacks

3 months ago

Will Xeris Biopharma (XERS) Report Negative Earnings Next Week? What You Should Know

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024
XERS

Business Wire

3 months ago

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?
XERS

Zacks

3 months ago

Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?

XERS

MT Newswires

3 months ago

Xeris Biopharma Appoints John Shannon as CEO

Xeris Biopharma Announces CEO Succession Plan
XERS

Business Wire

3 months ago

Xeris Biopharma Announces CEO Succession Plan

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
XERS

Business Wire

4 months ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit
XERS

Simply Wall St.

5 months ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024
XERS

Business Wire

5 months ago

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024

XERS

MT Newswires

5 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

XERS

MT Newswires

5 months ago

Xeris Biopharma Says Potential Levothyroxine Injection Preferred Over Oral Formulation; Shares Rise

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)
XERS

Business Wire

5 months ago

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

Xeris to Participate in the Jefferies Global Healthcare Conference
XERS

Business Wire

5 months ago

Xeris to Participate in the Jefferies Global Healthcare Conference

Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges
XERS

GuruFocus.com

5 months ago

Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
XERS

Insider Monkey

5 months ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations
XERS

Simply Wall St.

5 months ago

Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations

XERS

Thomson Reuters StreetEvents

5 months ago

Q1 2024 Xeris Biopharma Holdings Inc Earnings Call

Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates
XERS

Zacks

5 months ago

Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates

XERS

Associated Press Finance

5 months ago

Xeris Biopharma: Q1 Earnings Snapshot

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
XERS

Business Wire

5 months ago

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events

XERS

MT Newswires

6 months ago

Xeris Biopharma Collaborating With Beta Bionics for Development, Commercialization of Glucagon Product

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
XERS

ACCESSWIRE

6 months ago

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics

Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock
XERS

Simply Wall St.

6 months ago

Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
XERS

Business Wire

6 months ago

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
XERS

Zacks

6 months ago

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions
XERS

Simply Wall St.

7 months ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
XERS

Business Wire

7 months ago

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
XERS

Business Wire

7 months ago

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results
XERS

Simply Wall St.

7 months ago

Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results

Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023
XERS

GuruFocus.com

8 months ago

Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
XERS

Insider Monkey

8 months ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript

XERS

Thomson Reuters StreetEvents

8 months ago

Q4 2023 Xeris Biopharma Holdings Inc Earnings Call

Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
XERS

Zacks

8 months ago

Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates

XERS

Associated Press Finance

8 months ago

Xeris Biopharma: Q4 Earnings Snapshot

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
XERS

Business Wire

8 months ago

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
XERS

Business Wire

8 months ago

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

Why Xeris (XERS) Might Surprise This Earnings Season
XERS

Zacks

8 months ago

Why Xeris (XERS) Might Surprise This Earnings Season

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
XERS

Business Wire

8 months ago

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference
XERS

Business Wire

9 months ago

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

PIMCO Closed-End Funds Declare Monthly Common Share Distributions
XERS

GlobeNewswire

9 months ago

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Ahead of Groundhog Day, LendingTree Introduces Spring: A Fresh New App Where Smart Money Habits Take Root
XERS

PR Newswire

9 months ago

Ahead of Groundhog Day, LendingTree Introduces Spring: A Fresh New App Where Smart Money Habits Take Root

Logility Advances Supply Chain Supplier Management Capabilities for Apparel and Soft Goods Companies
XERS

Business Wire

9 months ago

Logility Advances Supply Chain Supplier Management Capabilities for Apparel and Soft Goods Companies

XERS

Investing.com

9 months ago

Dollar edges higher ahead of Fed meeting, payrolls

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?
XERS

Zacks

9 months ago

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?

Udemy to Announce Fourth Quarter and Full Year 2023 Results on February 14
XERS

GlobeNewswire

9 months ago

Udemy to Announce Fourth Quarter and Full Year 2023 Results on February 14

XERS

Thomson Reuters StreetEvents

9 months ago

Q4 2023 CrossFirst Bankshares Inc Earnings Call

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
XERS

Zacks

9 months ago

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Matterport to Announce Fourth Quarter & Full Year 2023 Results on February 20, 2024
XERS

GlobeNewswire

9 months ago

Matterport to Announce Fourth Quarter & Full Year 2023 Results on February 20, 2024

Compared to Estimates, CrossFirst (CFB) Q4 Earnings: A Look at Key Metrics
XERS

Zacks

9 months ago

Compared to Estimates, CrossFirst (CFB) Q4 Earnings: A Look at Key Metrics

Anterix (ATEX) Loses -13.76% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
XERS

Zacks

9 months ago

Anterix (ATEX) Loses -13.76% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza
XERS

Zacks

9 months ago

Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza

The RMR Group Announces Quarterly Dividend on Common Shares
XERS

Business Wire

9 months ago

The RMR Group Announces Quarterly Dividend on Common Shares

Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab
XERS

Business Wire

9 months ago

Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts
XERS

PR Newswire

9 months ago

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
XERS

InvestorPlace

9 months ago

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

Institutional owners may ignore Evolv Technologies Holdings, Inc.'s (NASDAQ:EVLV) recent US$65m market cap decline as longer-term profits stay in the green
XERS

Simply Wall St.

9 months ago

Institutional owners may ignore Evolv Technologies Holdings, Inc.'s (NASDAQ:EVLV) recent US$65m market cap decline as longer-term profits stay in the green

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors
XERS

GlobeNewswire

9 months ago

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
XERS

Business Wire

10 months ago

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MESA LABS DECLARES QUARTERLY DIVIDEND
XERS

GlobeNewswire

10 months ago

MESA LABS DECLARES QUARTERLY DIVIDEND

Xeris Biopharma Updates Its Outlook for 2023
XERS

Business Wire

10 months ago

Xeris Biopharma Updates Its Outlook for 2023

Enliven Therapeutics Inc CFO Benjamin Hohl Sells 11,870 Shares
XERS

GuruFocus.com

10 months ago

Enliven Therapeutics Inc CFO Benjamin Hohl Sells 11,870 Shares

Ultra Clean to Participate in 26th Annual Needham Growth Conference
XERS

PR Newswire

10 months ago

Ultra Clean to Participate in 26th Annual Needham Growth Conference

Investing in Covenant Logistics Group (NASDAQ:CVLG) three years ago would have delivered you a 196% gain
XERS

Simply Wall St.

10 months ago

Investing in Covenant Logistics Group (NASDAQ:CVLG) three years ago would have delivered you a 196% gain

Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
XERS

Business Wire

10 months ago

Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

11 High Growth Micro-Cap Stocks to Buy
XERS

Insider Monkey

10 months ago

11 High Growth Micro-Cap Stocks to Buy

Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc
XERS

GuruFocus.com

10 months ago

Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc

ATN International Announces Dividend & Share Buyout Hike
XERS

Zacks

10 months ago

ATN International Announces Dividend & Share Buyout Hike

Tandem Diabetes (TNDM) Avails Tandem Source in the United States
XERS

Zacks

10 months ago

Tandem Diabetes (TNDM) Avails Tandem Source in the United States

Aspire North America, LLC Enters Five-Year Exclusive Global Manufacturing and Distribution Agreement with Lifestyle Brand: BrkFst
XERS

PR Newswire

10 months ago

Aspire North America, LLC Enters Five-Year Exclusive Global Manufacturing and Distribution Agreement with Lifestyle Brand: BrkFst

Does FTAI Infrastructure (FIP) Have an Asymmetric Upside Opportunity?
XERS

Insider Monkey

10 months ago

Does FTAI Infrastructure (FIP) Have an Asymmetric Upside Opportunity?

Potential Upside For FTAI Infrastructure Inc. (NASDAQ:FIP) Not Without Risk
XERS

Simply Wall St.

10 months ago

Potential Upside For FTAI Infrastructure Inc. (NASDAQ:FIP) Not Without Risk

DISCO Publicly Launches Cecilia, an AI-Powered Platform for Legal Professionals to Transform their Workflows and Accelerate Fact Finding
XERS

Business Wire

a year ago

DISCO Publicly Launches Cecilia, an AI-Powered Platform for Legal Professionals to Transform their Workflows and Accelerate Fact Finding

16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds
XERS

Insider Monkey

a year ago

16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds

3 Stocks at the Forefront of Personalized Medicine Trend
XERS

InvestorPlace

a year ago

3 Stocks at the Forefront of Personalized Medicine Trend

Zhihu Inc. (NYSE:ZH) Q3 2023 Earnings Call Transcript
XERS

Insider Monkey

a year ago

Zhihu Inc. (NYSE:ZH) Q3 2023 Earnings Call Transcript

XERS

PR Newswire

a year ago

Zhihu Inc. Reports Unaudited Third Quarter 2023 Financial Results

Does CS Disco (LAW) Have the Potential to Rally 47.16% as Wall Street Analysts Expect?
XERS

Zacks

a year ago

Does CS Disco (LAW) Have the Potential to Rally 47.16% as Wall Street Analysts Expect?

Do Options Traders Know Something About TETRA Technologies (TTI) Stock We Don't?
XERS

Zacks

a year ago

Do Options Traders Know Something About TETRA Technologies (TTI) Stock We Don't?

President & COO of Xeris Biopharma Holdings Picks Up 7.5% More Stock
XERS

Simply Wall St.

a year ago

President & COO of Xeris Biopharma Holdings Picks Up 7.5% More Stock

XERS

PR Newswire

a year ago

Zhihu Inc. to Report Third Quarter 2023 Financial Results on November 29, 2023

CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript
XERS

Insider Monkey

a year ago

CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript

CryoPort Inc (CYRX) Faces Economic Headwinds but Sees Growth in Key Segments
XERS

GuruFocus.com

a year ago

CryoPort Inc (CYRX) Faces Economic Headwinds but Sees Growth in Key Segments

XERS

Associated Press Finance

a year ago

Lyell Immunopharma: Q3 Earnings Snapshot

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
XERS

GlobeNewswire

a year ago

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023

XERS

Associated Press Finance

a year ago

ICU Medical: Q3 Earnings Snapshot

Gladstone Land Corporation Earnings Call and Webcast Information
XERS

ACCESSWIRE

a year ago

Gladstone Land Corporation Earnings Call and Webcast Information

ICU Medical Announces Third Quarter 2023 Results
XERS

GlobeNewswire

a year ago

ICU Medical Announces Third Quarter 2023 Results

Share on Social Networks: